Networked Scanners

WHITE PAPERS AND CASE STUDIES

• Luxury Beauty Products & Fragrances Retailer Addresses New Increased Order Volume With Voice Picking And Packing

  Leading US retailer specializing in luxury beauty products and fragrances has been partnered with Radial since 2005 for fulfillment operations. With business growing substantially, there was a need to address increased order volumes, along with speed and accuracy.

• Laundry Innovator WASH Multifamily Laundry Systems Drives Field Service Efficiency And Enhances Customer Experience

  When laundry powerhouse WASH realized that a lack of access to accurate parts and technical information hindered efficiency and accuracy within their support organizations, they turned to AnswersAnywhere to create a mobile "single source of truth" for their field service technicians and customer support staff. 

• An Alternative To 2D Western Blot

  In this paper evaluates three methods to analyze the coverage of polyclonal antibodies to a population of host cell proteins using two-dimensional separation.

• When ‘Okay’ Data Protection Is Not Enough

  Contigo Technologies is a leading MSP based in Austin, Texas. While many MSPs focus on particular verticals, Contigo’s technical and service offerings have made them the “go-to” MSP for businesses across the Austin area. An example of their commitment to customer service is that they place an icon on every supported workstation that lets the user contact Contigo in a matter of seconds, whether to access support or just ask a question.

• Camuzzi Gas: Planning And Mobilization Of Field Service Activities

  Camuzzi Gas Pampeana S.A. and Camuzzi Gas del Sur S.A. form the largest supplier of natural gas in Argentina, covering around 45% of the country, i.e. a 3,100 km wide area. The companies serve 2.5 million clients and manage 10,000 km of gas pipelines as well as a 50.000 km long gas supply network.

• Optimal Outcomes In Clinical Research And Product Development

  Find out why innovators turn to contract research organizations (CROs) for additional preclinical and clinical expertise and resources to help complement internal capabilities. 

• Ora Streamlines Clinical Trials With Veeva Vault CTMS And BA Insight AppBus Platform

  Ora, a full-service contract research organization specializing in ophthalmology, aims to accelerate development timelines for its sponsor clients, so productivity and efficiency are critical to delivering high-quality engagements. To achieve its goal of providing best-in-class clinical services, Ora easily integrates Vault CTMS with other applications using the BA Insight AppBus low-code platform.

• Most Common Reasons For FDA Form 483 Observations And Warning Letters In Medical Device Environments

  When the FDA conducts regulatory inspections, issues that are considered objectionable conditions or compliance violations by FDA inspectors are itemized in a Form 483 or a warning letter. In this article, we help you understand the FDA’s updated approach to medical device regulation and provide information about inspection observations so you identify and mitigate compliance issues more easily.

• Providing Research Participants With New Information – Is Re-Consent Always Necessary

  In an ever-changing clinical research landscape, it is critical that we are agile, flexible, and quick to adapt to change. But what if that change impacts currently enrolled study participants? How do we communicate changes to the study effectively and in line with regulatory guidance? This whitepaper provides tips and strategies for how to handle consent documentation with participants when new information becomes available.

• CRO Leverages Partnership With Integrated Central IBC To Initiate Sites In COVID-19 Vaccine Research

  The COVID-19 pandemic forced a CRO to reimagine what was possible as it became clear traditional timelines would not be sufficient to move the new COVID vaccines through clinical trials and to the public at warp speed. Working with Advarra, they were able accelerate review times so the COVID vaccine trial sites could progress through site selection, IRB/IBC submission, approval, drug shipment, and complete site initiation visits in record time.

• FDA's Q&A On 21 CFR Part 11 For Clinical Investigations

  Examine six of the more significant points from the draft guidance, specifically as they pertain to the electronic Trial Master File.

• Monoclonal Antibody Manufacturing: Build Or Outsource?

  The standardization of biologics manufacturing processes has given product developers multiple viable options for producing monoclonal antibodies (mAbs), including building an in-house mAb production system or partnering with a contract biologics manufacturer.